CLS Holdings USA, Inc.

CLSH.CN · Canadian Securities Exchange · CAD

0,035CAD

−0,01 (−22,22 %)Stand 3. Juli, 14:16

Vortag 0,045

Kennzahlen

Eröffnung
0,035
Vortag
0,045
Tagesspanne
0,035 – 0,035
52 Wochen
0,015 – 0,095
Volumen
16.000
Ø Volumen
4724
Börsenwert
8,11 Mio. CAD
KGV
–
Gewinn je Aktie (TTM)
–
Dividendenrendite
–
Beta
1,2
Nächste Zahlen
–

Finanzen

Gerade nicht verfügbar.

Bewertung

Gerade nicht verfügbar.

Analysten

Einstufungen

Gerade nicht verfügbar.

Kursziel

Gerade nicht verfügbar.

Quartalszahlen

Gerade nicht verfügbar.

Dividenden und Splits

Gerade nicht verfügbar.

Aktiensplits

Gerade nicht verfügbar.

Eigentümer

Institutionen

Gerade nicht verfügbar.

Insider-Geschäfte

Gerade nicht verfügbar.

Vergleichbare Unternehmen

Gerade nicht verfügbar.

Über das Unternehmen

CLS Holdings USA, Inc. is a multifaceted cannabis enterprise operating throughout the United States. The company primarily focuses on extracting cannabinoids from cannabis plants and transforming them into various concentrated forms, such as oils, waxes, edibles, and shatters. Beyond these conversions, CLS Holdings supplies organic medical cannabis to authorized retailers and provides recreational marijuana products to licensed distributors and retailers. It also offers extraction derivatives, like oils and waxes, derived from its internal production. The company further extends its offerings to licensed medical cannabis cultivators by providing processing and extraction services, along with cannabis strains in the form of vegetative cuttings. Additionally, CLS Holdings provides consulting services to various cannabis-related businesses, including growers, dispensaries, and laboratories, and performs toll processing. Its products are marketed under the Oasis Cannabis and City Trees brand names, with its concentrates utilized for pharmaceutical and other applications. Established in 2014, CLS Holdings USA, Inc. is based in Miami, Florida.

CEO
Andrew J. Glashow
Mitarbeitende
80
Hauptsitz
Las Vegas, FL, US
Sektor
Healthcare
Branche
Drug Manufacturers - Specialty & Generic
Börsengang
8. Jan. 2019

Nachrichten

Gerade nicht verfügbar.

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.